Esophagitis is inflammation of esophagus mucous membranes, which may occur acutely or chronically. According to WHO, today this disease affects about 40% of the world population. The overwhelming majority of patients are men 30 to 50 years old. The treatment of esophagitis is reduced to elimination of symptoms and prevention of further relapses.
The treatment tactics is chosen based on the diagnostics results. During the first visit, the physician clarifies the complaints, collects the case history and conducts a clinical examination. Additionally, the patient is prescribed:
- complete and biochemical blood counts,
- abdominal ultrasound,
- urease test for Helicobacter pylori (bacteria causing inflammation of the mucous membranes).
In patients with H. pylori, 10% of esophagitis cases lead to development of esophageal cancer. In order to detect the pathology at an early stage, the physician asks to pass a hemoccult test (a fecal test for occult blood). Gastroscopy and biopsy are performed for the same purpose.
All patients are indicated the nutritional therapy. Drug treatment is chosen based on disease features. During treatment, the patient is closely monitored by medical staff. If H. pylori is found, the antibiotics are prescribed. To relieve the symptoms, the antacids, proton pump inhibitors and other drugs may be recommended. Individual guidelines are produced for each case to help prevent the further disease progression.